Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Spanish Network for Research in Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain.
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01083-17. Print 2017 Dec.
The global emergence of azole-resistant strains is a growing public health concern. Different patterns of azole resistance are linked to mutations in Therefore, accurate characterization of the mechanisms underlying azole resistance is critical to guide selection of the most appropriate antifungal agent for patients with aspergillosis. This study describes a new sequencing-free molecular screening tool for early detection of the most frequent mutations known to be associated with azole resistance in PCRs targeting mutations at positions G54, Y121, G448, and M220 and targeting different tandem repeats (TRs) in the promoter region were designed. All PCRs were performed simultaneously, using the same cycling conditions. Amplicons were then distinguished using a high-resolution melting assay. For standardization, 30 well-characterized azole-resistant strains were used, yielding melting curve clusters for different resistance mechanisms for each target and allowing detection of the most frequent azole resistance mutations, i.e., G54E, G54V, G54R, G54W, Y121F, M220V, M220I, M220T, M220K, and G448S, and the tandem repeats TR, TR, and TR Validation of the method was performed using a blind panel of 80 azole-susceptible or azole-resistant strains. All strains included in the blind panel were properly classified as susceptible or resistant with the developed method. The implementation of this screening method can reduce the time needed for the detection of azole-resistant isolates and therefore facilitate selection of the best antifungal therapy in patients with aspergillosis.
唑类耐药菌株在全球的出现是一个日益严重的公共卫生问题。不同的唑类耐药模式与 基因突变有关。因此,准确描述唑类耐药的机制对于指导曲霉菌病患者选择最合适的抗真菌药物至关重要。本研究描述了一种新的无测序分子筛选工具,用于早期检测与唑类耐药相关的最常见突变,该突变位于 G54、Y121、G448 和 M220 位置,针对不同串联重复(TR)的 PCR 设计了 。所有 PCR 均采用相同的循环条件同时进行。然后使用高分辨率熔解分析区分扩增子。为了标准化,使用了 30 株经过充分表征的唑类耐药 菌株,为每个靶标产生了不同耐药机制的熔解曲线簇,从而能够检测到最常见的唑类耐药突变,即 G54E、G54V、G54R、G54W、Y121F、M220V、M220I、M220T、M220K 和 G448S 以及串联重复 TR、TR 和 TR。使用 80 株唑类敏感或耐药的盲法面板验证了该方法。使用开发的方法可以正确地将盲法面板中的所有菌株分类为敏感或耐药。该筛选方法的实施可以减少检测唑类耐药 分离株所需的时间,从而有助于为曲霉菌病患者选择最佳的抗真菌治疗。